Similar Items

Cover Image

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

Background Direct oral anticoagulants are administered in fixed doses irrespective of body weight, but guidelines recommend against their use in patients with extremes of body weight. Objectives This study determined the effects of dual-pathway inhibition antithrombotic regimen (rivaroxaban 2.5 m...

Full description

Saved in:
Bibliographic Details
Institution:Universidad EIA
Main Authors: Guzik, Tomasz J., Ramasundarahettige, Chinthanie, Pogosova, Nana, Lopez-Jaramillo, Patricio, Dyal, Leanne, Berkowitz, Scott D., Muehlhofer, Eva, Bhatt, Deepak L., Fox, Keith A., Yusuf, Salim, Eikelboom, John W., Masira
Format: Artículo de revista
Language:English
Published: JACC Journals 2021-02-05
Online Access:https://repositorio.udes.edu.co/handle/001/6128
Tags: Add Tag
No Tags, Be the first to tag this record!